12 employees
Olatec is a biopharmaceutical company developing a platform to treat and prevent acute and chronic inflammatory diseases.
2003
$40M
from 3 investors over 3 rounds
Olatec Therapeutics LLC raised $40M on February 23, 2023
Investors: Sanders Morris Harris, MIP - Milano Investment Partners and Advection Growth Capital